About René Knijnenburg | Director Compensation Benefits, Genmab
About René Knijnenburg | Director Compensation Benefits, Genmab
Rene Knijnenburg, a seasoned HR C&B specialist, brings extensive expertise in the field of labor relations, including total rewards strategy. His extensive experience includes impactful HR positions at leading (inter)national companies such as Lucent Technologies, Rabobank and PGGM. Two years ago, Rene took on the position of Compensation & Benefits Director for Europe at Genmab.
About Genmab
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company is the creator of the following approved antibodies: DARZALEX®, Arzerra, TEPEZZA®, Kesimpta® and DARZALEX FASPRO™. Genmab also has a broad clinical and pre-clinical product pipeline. Genmab's technology base consists of validated and proprietary next generation antibody technologies such as the DuoBody®, HexaBody® and the HexElect® platform. Genmab has alliances with top tier pharmaceutical and biotechnology companies and is headquartered in Copenhagen, Denmark with sites in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
| Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | | |
© Copyright 2020 by Hyphen Projects